Literature DB >> 21201459

1,2,3,4-Tetra-hydro-isoquinoline-2-sulfonamide.

Radia Bouasla, Malika Berredjem, Nour-Eddine Aouf, Carole Barbey.   

Abstract

The title compound, C(9)H(12)N(2)O(2)S, is a useful precursor of a variety of modified sulfonamide mol-ecules. Due to the importance of these mol-ecules in biological systems (antibacterials, antidepressants and many other applications), there is a growing inter-est in the discovery of new biologically active compounds. In the title compound, the mol-ecules are linked by N-H⋯O inter-molecular hydrogen bonds involving the sulfonamide function to form an infinite two-dimensional network parallel to the (001) plane.

Entities:  

Year:  2008        PMID: 21201459      PMCID: PMC2960235          DOI: 10.1107/S1600536807068158

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For related literature, see: Berredjem et al. (2000 ▶); Lee & Lee (2002 ▶); Martinez et al. (2000 ▶); Xiao & Timberlake (2000 ▶); Esteve & Bidal (2002 ▶); Soledade et al. (2006 ▶).

Experimental

Crystal data

C9H12N2O2S M = 212.27 Monoclinic, a = 5.275 (1) Å b = 9.541 (1) Å c = 10.229 (1) Å β = 101.80 (5)° V = 503.93 (15) Å3 Z = 2 Mo Kα radiation μ = 0.30 mm−1 T = 293 (2) K 0.10 × 0.10 × 0.10 mm

Data collection

Nonius KappaCCD diffractometer Absorption correction: none 8285 measured reflections 2210 independent reflections 2106 reflections with I > 2σ(I) R int = 0.032

Refinement

R[F 2 > 2σ(F 2)] = 0.030 wR(F 2) = 0.087 S = 1.13 2210 reflections 127 parameters 1 restraint H-atom parameters constrained Δρmax = 0.25 e Å−3 Δρmin = −0.30 e Å−3 Absolute structure: Flack (1983 ▶), 979 Friedel pairs Flack parameter: −0.01 (6) Data collection: COLLECT (Hooft, 1998 ▶); cell refinement: DENZO/SCALEPACK (Otwinowski & Minor, 1997 ▶); data reduction: COLLECT; program(s) used to solve structure: SHELXS97 (Sheldrick, 1997 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 1997 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997 ▶) and PLATON (Spek, 2003 ▶); software used to prepare material for publication: SHELXL97 and CrystalBuilder (DECOMET Laboratory, 2007 ▶). Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536807068158/dn2304sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536807068158/dn2304Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C9H12N2O2SF000 = 224
Mr = 212.27Dx = 1.399 Mg m3
Monoclinic, P21Mo Kα radiation λ = 0.71070 Å
Hall symbol: P 2ybCell parameters from 6025 reflections
a = 5.275 (1) Åθ = 2.0–27.5º
b = 9.541 (1) ŵ = 0.30 mm1
c = 10.229 (1) ÅT = 293 (2) K
β = 101.80 (5)ºParallelepipedic, yellow
V = 503.93 (15) Å30.10 × 0.10 × 0.10 mm
Z = 2
Nonius KappaCCD diffractometer2210 independent reflections
Radiation source: fine-focus sealed tube2106 reflections with I > 2σ(I)
Monochromator: graphiteRint = 0.032
Detector resolution: 9 pixels mm-1θmax = 27.5º
T = 293(2) Kθmin = 2.0º
φ and ω scansh = −6→6
Absorption correction: nonek = −12→11
8285 measured reflectionsl = −13→13
Refinement on F2Hydrogen site location: inferred from neighbouring sites
Least-squares matrix: fullH-atom parameters constrained
R[F2 > 2σ(F2)] = 0.030  w = 1/[σ2(Fo2) + (0.0575P)2 + 0.0148P] where P = (Fo2 + 2Fc2)/3
wR(F2) = 0.087(Δ/σ)max < 0.001
S = 1.13Δρmax = 0.25 e Å3
2210 reflectionsΔρmin = −0.30 e Å3
127 parametersExtinction correction: none
1 restraintAbsolute structure: Flack (1983), 979 Friedel pairs
Primary atom site location: structure-invariant direct methodsFlack parameter: −0.01 (6)
Secondary atom site location: difference Fourier map
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
S10.56649 (7)0.52966 (4)0.42439 (3)0.03710 (13)
N10.4887 (3)0.60389 (14)0.27757 (14)0.0369 (3)
C30.5408 (4)0.7557 (2)0.2719 (2)0.0475 (5)
H3A0.69930.77920.33450.057*
H3B0.39980.80870.29560.057*
O20.8298 (3)0.5665 (2)0.47635 (14)0.0624 (5)
C60.1947 (4)0.6250 (2)0.06005 (17)0.0415 (4)
C70.2282 (4)0.5698 (2)0.20079 (17)0.0451 (4)
H7A0.09850.61120.24390.054*
H7B0.20380.46900.19870.054*
C80.3113 (5)0.7727 (3)−0.1068 (2)0.0608 (6)
H80.41950.8406−0.13110.073*
C90.3522 (4)0.7280 (2)0.02630 (18)0.0442 (4)
C100.1146 (5)0.7182 (3)−0.2021 (2)0.0631 (6)
H100.08880.7499−0.28980.076*
C11−0.0028 (5)0.5703 (3)−0.0374 (2)0.0611 (6)
H11−0.10980.5009−0.01460.073*
C12−0.0432 (5)0.6172 (3)−0.1677 (2)0.0669 (7)
H12−0.17730.5802−0.23170.080*
C130.5667 (4)0.7918 (2)0.1305 (2)0.0538 (5)
H13A0.56360.89290.12000.065*
H13B0.73250.75820.11620.065*
O10.4929 (3)0.38595 (15)0.40334 (14)0.0580 (4)
N20.4032 (3)0.59065 (17)0.52808 (16)0.0426 (3)
H210.44780.67960.55400.051*
H220.23550.55960.51090.051*
U11U22U33U12U13U23
S10.0370 (2)0.0412 (2)0.03170 (18)0.00882 (17)0.00373 (13)0.00083 (17)
N10.0378 (8)0.0365 (8)0.0340 (6)0.0022 (6)0.0012 (5)0.0019 (6)
C30.0564 (12)0.0391 (10)0.0451 (10)−0.0060 (8)0.0055 (9)0.0004 (8)
O20.0313 (7)0.1054 (14)0.0475 (7)0.0094 (7)0.0011 (5)0.0075 (8)
C60.0424 (10)0.0444 (9)0.0356 (8)0.0066 (8)0.0029 (7)0.0031 (7)
C70.0430 (9)0.0500 (11)0.0385 (8)−0.0071 (8)−0.0008 (7)0.0080 (7)
C80.0667 (15)0.0737 (15)0.0458 (11)0.0099 (12)0.0204 (11)0.0167 (11)
C90.0457 (9)0.0485 (10)0.0399 (8)0.0096 (8)0.0122 (8)0.0069 (8)
C100.0767 (15)0.0790 (15)0.0340 (9)0.0256 (13)0.0121 (10)0.0077 (10)
C110.0631 (13)0.0690 (14)0.0434 (10)−0.0081 (11)−0.0069 (9)0.0031 (9)
C120.0745 (15)0.0789 (17)0.0395 (10)0.0129 (13)−0.0066 (10)−0.0040 (10)
C130.0525 (12)0.0564 (13)0.0514 (11)−0.0089 (10)0.0080 (9)0.0130 (10)
O10.0933 (12)0.0335 (7)0.0448 (7)0.0131 (7)0.0087 (7)0.0030 (6)
N20.0424 (8)0.0439 (8)0.0431 (8)−0.0024 (6)0.0122 (6)−0.0091 (7)
S1—O21.4261 (16)C8—C101.373 (4)
S1—O11.4293 (16)C8—C91.401 (3)
S1—N21.6060 (16)C8—H80.9300
S1—N11.6350 (14)C9—C131.515 (3)
N1—C71.473 (2)C10—C121.366 (4)
N1—C31.478 (2)C10—H100.9300
C3—C131.520 (3)C11—C121.380 (3)
C3—H3A0.9700C11—H110.9300
C3—H3B0.9700C12—H120.9300
C6—C91.376 (3)C13—H13A0.9700
C6—C111.388 (3)C13—H13B0.9700
C6—C71.509 (2)N2—H210.9059
C7—H7A0.9700N2—H220.9154
C7—H7B0.9700
O2—S1—O1120.43 (11)C10—C8—C9121.3 (2)
O2—S1—N2106.12 (10)C10—C8—H8119.4
O1—S1—N2106.34 (10)C9—C8—H8119.4
O2—S1—N1106.13 (10)C6—C9—C8118.7 (2)
O1—S1—N1105.53 (8)C6—C9—C13120.86 (17)
N2—S1—N1112.45 (9)C8—C9—C13120.4 (2)
C7—N1—C3110.85 (15)C12—C10—C8119.7 (2)
C7—N1—S1115.19 (12)C12—C10—H10120.1
C3—N1—S1116.54 (12)C8—C10—H10120.1
N1—C3—C13108.23 (16)C12—C11—C6121.1 (2)
N1—C3—H3A110.1C12—C11—H11119.5
C13—C3—H3A110.1C6—C11—H11119.5
N1—C3—H3B110.1C10—C12—C11119.7 (2)
C13—C3—H3B110.1C10—C12—H12120.1
H3A—C3—H3B108.4C11—C12—H12120.1
C9—C6—C11119.43 (18)C9—C13—C3112.27 (17)
C9—C6—C7122.01 (17)C9—C13—H13A109.1
C11—C6—C7118.57 (18)C3—C13—H13A109.1
N1—C7—C6110.24 (15)C9—C13—H13B109.1
N1—C7—H7A109.6C3—C13—H13B109.1
C6—C7—H7A109.6H13A—C13—H13B107.9
N1—C7—H7B109.6S1—N2—H21113.0
C6—C7—H7B109.6S1—N2—H22112.6
H7A—C7—H7B108.1H21—N2—H22122.9
D—H···AD—HH···AD···AD—H···A
N2—H21···O1i0.912.032.928 (2)173
N2—H22···O2ii0.922.102.971 (2)159
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N2—H21⋯O1i0.912.032.928 (2)173
N2—H22⋯O2ii0.922.102.971 (2)159

Symmetry codes: (i) ; (ii) .

  2 in total

1.  Nonnucleoside human cytomegalovirus inhibitors: synthesis and antiviral evaluation of (chlorophenylmethyl)benzothiadiazine dioxide derivatives.

Authors:  A Martinez; C Gil; C Perez; A Castro; C Prieto; J Otero; G Andrei; R Snoeck; J Balzarini; E De Clercq
Journal:  J Med Chem       Date:  2000-08-24       Impact factor: 7.446

2.  Toward the control of Leptosphaeria maculans: design, syntheses, biological activity, and metabolism of potential detoxification inhibitors of the crucifer phytoalexin brassinin.

Authors:  M Soledade C Pedras; Mukund Jha
Journal:  Bioorg Med Chem       Date:  2006-04-17       Impact factor: 3.641

  2 in total
  3 in total

1.  Crystal structure and Hirshfeld surface analysis of 2-{[7-acetyl-4-cyano-6-hy-droxy-8-(4-meth-oxyphen-yl)-1,6-dimethyl-5,6,7,8-tetra-hydro-isoquinolin-3-yl-]sulfan-yl}acetic acid ethyl ester.

Authors:  Elham A Al-Taifi; Islam S Marae; Yasser A El-Ossaily; Shaaban K Mohamed; Joel T Mague; Mehmet Akkurt; Etify A Bakhite
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2022-01-25

2.  Synthesis and antitumor evaluation of novel sulfonylcycloureas derived from nitrogen mustard.

Authors:  H Cheloufi; B Belhani; T S Ouk; R Zerrouki; N-E Aouf; M Berredjem
Journal:  Mol Divers       Date:  2015-11-23       Impact factor: 2.943

3.  Synthesis, in silico study (DFT, ADMET) and crystal structure of novel sulfamoyloxy-oxazolidinones: Interaction with SARS-CoV-2.

Authors:  Abdeslem Bouzina; Malika Berredjem; Sofiane Bouacida; Khaldoun Bachari; Christelle Marminon; Marc Le Borgne; Zouhair Bouaziz; Yousra Ouafa Bouone
Journal:  J Mol Struct       Date:  2022-02-05       Impact factor: 3.841

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.